Company
United StatesPublic company, NASDAQ: NVCRNovocure, Inc (NASDAQ: NVCR), Portsmouth, NH – FDA Inspections
Inspection records and compliance data for Novocure, Inc in Portsmouth, New Hampshire. 4 FDA inspections on record, last inspected February 09, 2024. Publicly traded as NASDAQ: NVCR.
Company Profile
This profile covers Novocure, Inc based in Portsmouth, New Hampshire, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected October 10, 2012. Last inspected February 9, 2024.
Most cited issue areas
- Lack of or inadequate complaint procedures1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 9, 2024 | VAI | Medical Devices & Rad Health · Project Evaluation: Devices | 1228963 |
| March 29, 2018 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1048425 |
| January 7, 2015 | NAI | Medical Devices & Rad Health · Compliance: Devices | 918358 |
| October 10, 2012 | NAI | Medical Devices & Rad Health · Compliance: Devices | 802637 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novocure, Inc
Stock ticker
NVCR
Exchange
NASDAQ
Share price
$11.72
Market cap
$1.4B
Price as of
November 13, 2026
FEI Number
3009306483
Address
195 Commerce Way, Portsmouth, New Hampshire 03801, United States
Country
United States
ID: 2cea52c1-928b-4c11-aa23-77452436748f